BIOCON PHARMA INC
BIOCON PHARMA INC appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0306-2025, Class II) was initiated on March 17, 2025.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Known Names
biocon pharma, biocon pharma inc
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0306-2025 | Class II | Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma | March 17, 2025 |
| D-0268-2023 | Class II | Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pha | January 31, 2023 |